Pfizer requesting emergency use authorization for COVID-19 vaccine for kids 5-11

Pfizer-BioNTech requested Tuesday that the U.S. Food and Drug Administration (FDA) extend its COVID-19 vaccine emergency use authorization for children ages 5 to 11.